XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid in capital
Accumulated deficit
Accumulated comprehensive income (loss)
Noncontrolling interest
Beginning balance, common stock (in shares) at Dec. 31, 2021   117,751,000        
Beginning balance, common stock at Dec. 31, 2021 $ 65,536 $ 15 $ 294,190 $ (228,667) $ (2) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee stock option and stock awards plans (in shares)   2,459,000        
Issuance of common stock under employee stock option and stock award plans 1,305   1,305      
Repurchase of common stock (in shares)   (67,000)        
Repurchase of common stock (550)   (550)      
Exercise of warrants (in shares)   3,318,000        
Exercise of warrants 29,641   29,641      
Stock-based compensation expense related to employee and non-employee stock awards 24,072   24,072      
Foreign currency translation adjustment (60)       (60)  
Net income (loss) 79,792     79,792    
Ending balance, common stock (in shares) at Mar. 31, 2022   123,461,000        
Ending balance, common stock at Mar. 31, 2022 $ 199,736 $ 15 348,658 (148,875) (62) 0
Beginning balance, common stock (in shares) at Dec. 31, 2022 153,628,838 153,629,000        
Beginning balance, common stock at Dec. 31, 2022 $ 384,760 $ 18 535,875 (154,754) (7) 3,628
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee stock option and stock awards plans (in shares)   3,082,000        
Issuance of common stock under employee stock option and stock award plans 2,925   2,925      
Shares issued in connection with buyout agreement (in shares)   4,232,000        
Shares issued in connection with buyout agreement 4,399   7,509     (3,110)
Stock-based compensation expense related to employee and non-employee stock awards 14,884   14,884      
Foreign currency translation adjustment 0          
Net income (loss) $ (62,365)     (61,847)   (518)
Ending balance, common stock (in shares) at Mar. 31, 2023 160,943,107 160,943,000        
Ending balance, common stock at Mar. 31, 2023 $ 344,603 $ 18 $ 561,193 $ (216,601) $ (7) $ 0